A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE Reply

被引：21

作者：

Salloway, S. P.

Black, R.

Sperling, R.

Fox, N.

Gilman, S.

Schenk, D.

Grundman, M.

机构：

来源：

NEUROLOGY | 2010年 / 74卷 / 24期

关键词：

CEREBRAL AMYLOID ANGIOPATHY; APOLIPOPROTEIN-E; APOE;

D O I：

10.1212/WNL.0b013e3181e03844

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2026 / 2027

页数：2

共 9 条

[1] Consequence of A immunization on the vasculature of human Alzheimers disease brain [J].

Boche, D. ;

Zotova, E. ;

Weller, R. O. ;

Love, S. ;

Neal, J. W. ;

Pickering, R. M. ;

Wilkinson, D. ;

Holmes, C. ;

Nicoll, J. A. R. .

BRAIN, 2008, 131 :3299-3310

[2] APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein [J].

Chalmers, K ;

Wilcock, GK ;

Love, S .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (03) :231-238

[3] Course of cerebral amyloid angiopathy - related inflammation [J].

Kinnecom, C. ;

Lev, M. H. ;

Wendell, L. ;

Smith, E. E. ;

Rosand, J. ;

Frosch, M. P. ;

Greenberg, S. M. .

NEUROLOGY, 2007, 68 (17) :1411-1416

[4] Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides [J].

Laskowitz, DT ;

Thekdi, AD ;

Thekdi, SD ;

Han, SKD ;

Myers, JK ;

Pizzo, SV ;

Bennett, ER .

EXPERIMENTAL NEUROLOGY, 2001, 167 (01) :74-85

[5] Reversible leukoencephalopathy associated with cerebral amyloid angiopathy [J].

Oh, U ;

Gupta, R ;

Krakauer, JW ;

Khandji, AG ;

Chin, SS ;

Elkind, MSV .

NEUROLOGY, 2004, 62 (03) :494-497

[6] A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease [J].

Salloway, S. ;

Sperling, R. ;

Gilman, S. ;

Fox, N. C. ;

Blennow, K. ;

Raskind, M. ;

Sabbagh, M. ;

Honig, L. S. ;

Doody, R. ;

van Dyck, C. H. ;

Mulnard, R. ;

Barakos, J. ;

Gregg, K. M. ;

Liu, E. ;

Lieberburg, I. ;

Schenk, D. ;

Black, R. ;

Grundman, M. .

NEUROLOGY, 2009, 73 (24) :2061-2070

[7] BINDING OF HUMAN APOLIPOPROTEIN-E TO SYNTHETIC AMYLOID-BETA PEPTIDE - ISOFORM-SPECIFIC EFFECTS AND IMPLICATIONS FOR LATE-ONSET ALZHEIMER-DISEASE [J].

STRITTMATTER, WJ ;

WEISGRABER, KH ;

HUANG, DY ;

DONG, LM ;

SALVESEN, GS ;

PERICAKVANCE, M ;

SCHMECHEL, D ;

SAUNDERS, AM ;

GOLDGABER, D ;

ROSES, AD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8098-8102

[8] NSAID use and dementia risk in the cardiovascular health study - Role of APOE and NSAID type [J].

Szekely, C. A. ;

Breitner, J. C. S. ;

Fitzpatrick, A. L. ;

Rea, T. D. ;

Psaty, B. M. ;

Kuller, L. H. ;

Zandi, P. P. .

NEUROLOGY, 2008, 70 (01) :17-24

[9] Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions [J].

Tlaskowitz, Daniel ;

Vitek, Michael P. .

PHARMACOGENOMICS, 2007, 8 (08) :959-969

← 1 →